A carregar...
The role of immune checkpoint inhibition in the treatment of ovarian cancer
The introduction of immune checkpoint inhibitors has revolutionized treatment of multiple cancers and has bolstered interest in this treatment approach. So far, emerging clinical data show limited clinical efficacy of these agents in ovarian cancer with objective response rates of 10–15% with some d...
Na minha lista:
| Publicado no: | Gynecol Oncol Res Pract |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122024/ https://ncbi.nlm.nih.gov/pubmed/27904752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-016-0033-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|